Birdwatch Note
2022-12-01 14:04:50 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This refers to an in-vitro lab experiment and not a human trial. https://www.monash.edu/discovery-institute/news-and-events/news/2021-articles/monash-university-update-on-ivermectin-research NIH has approved the use of Ivermectin as a Sars-CoV2 treatment ONLY in ongoing clinical trials. Ivermectin is widely used and well tolerated in humans: https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/ FDA is currently being sued regarding Ivermectin https://finance.yahoo.com/news/fda-misled-public-ivermectin-accountable-144900899.html?fr=sycsrp_catchall
Written by C114AE7443E7B8F37927077AEBFF939CF496CCF90C3DC24ACA95F015E2AB6DC7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1597758757798547457
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1598317200175251458
- noteId - 1598317200175251458
- participantId - C114AE7443E7B8F37927077AEBFF939CF496CCF90C3DC24ACA95F015E2AB6DC7
- noteAuthorParticipantId -
- createdAtMillis - 1669903490474
- tweetId - 1597758757798547457
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This refers to an in-vitro lab experiment and not a human trial. https://www.monash.edu/discovery-institute/news-and-events/news/2021-articles/monash-university-update-on-ivermectin-research NIH has approved the use of Ivermectin as a Sars-CoV2 treatment ONLY in ongoing clinical trials. Ivermectin is widely used and well tolerated in humans: https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/ FDA is currently being sued regarding Ivermectin https://finance.yahoo.com/news/fda-misled-public-ivermectin-accountable-144900899.html?fr=sycsrp_catchall
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2022-12-01 14:04:50 UTC (1669903490474) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
C114AE7443E7B8F37927077AEBFF939CF496CCF90C3DC24ACA95F015E2AB6DC7 |
Note Ratings
| rated at | rated by | |
| 2022-12-03 14:13:42 -0600 | 074D27E223FD6188E9C2368CD84FB54FED7BDC7A750524017F6227E5D1C5E93F | Rating Details |
| 2022-12-02 08:04:40 -0600 | 0E3F6EB4AAF7233033251BACE0F0325D12DBDA5E1D67354D15807134017D9D96 | Rating Details |
| 2022-12-01 12:41:36 -0600 | 0F216099A339D0D32175FD908411C8EC678482567B79B561C8EBB42BC1921AE3 | Rating Details |
| 2022-12-01 10:20:13 -0600 | 1336446E52147E5398266C3CB3FCB8413DA3543F8852EB9FACA1B561C812C9E5 | Rating Details |
| 2022-12-05 02:34:28 -0600 | 31F2E944B69749081C110466887C8B7639EE357B5515AC2B34C86CD1CE114E43 | Rating Details |
| 2022-12-01 20:28:51 -0600 | 3922021E2B4C1A4B610B8FAFE0447925B4441B7A397CBAE1E446B9DE65C2A8E3 | Rating Details |
| 2022-12-02 06:41:07 -0600 | 4302ABC07DA193A79D3A57D2E3B24B34208EDD84A6A4ED0926553626742493A8 | Rating Details |
| 2022-12-01 10:19:48 -0600 | 4BEDF4F159165B4871D02B3BD7B43A1AA3C700DE65A6CA1064226E7EE15BFD69 | Rating Details |
| 2022-12-01 11:10:44 -0600 | 547B46B38A1CB3060240F9F561852ADB212E08AA27CDAE1D9BE8DDCD9A5D2518 | Rating Details |
| 2022-12-01 08:51:33 -0600 | 6E76CE163012825DBEB32807367391AE32594E8CAB1349174CD7BD5FFCD9F591 | Rating Details |
| 2022-12-01 08:52:48 -0600 | 70C181B24233FF8251A370E67F314FF2678F046BCC2BD211A42D44AC787BC7DC | Rating Details |
| 2022-12-01 10:30:04 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
| 2022-12-01 08:20:50 -0600 | 95F7A3EB2A168CA64B3E872F9D7C23876AA4B35589501BF82B47671AC4AA3217 | Rating Details |
| 2022-12-01 12:02:00 -0600 | 96259C16C38458FE7A8A6C293A8049357F7D3EC2D0F557E58FD8034ED6400C1F | Rating Details |
| 2022-12-01 09:49:08 -0600 | A0B58341951F910E220D2AE0080B908B883C7499CF480E4CE1DA476769955D31 | Rating Details |
| 2022-12-01 09:06:46 -0600 | A4125342C664F246ADA997FDA2127A9A36AF81549808882E6E2B96C0929DDED7 | Rating Details |
| 2022-12-01 10:54:29 -0600 | A86C0F99F8EC1ADC946170050AEB69905C4F1D1514244E999455FF71F57C7151 | Rating Details |
| 2022-12-01 10:16:27 -0600 | DBC322B9382DDED44E9CCC0019C17752740C91A86743EC20A05A6804A000E383 | Rating Details |
| 2022-12-04 16:52:01 -0600 | Rating Details | |
| 2022-12-01 09:06:46 -0600 | Rating Details | |
| 2022-12-01 10:19:48 -0600 | Rating Details | |
| 2022-12-03 14:13:42 -0600 | Rating Details | |
| 2022-12-01 08:52:48 -0600 | Rating Details | |
| 2022-12-01 08:20:50 -0600 | Rating Details | |
| 2022-12-01 10:16:27 -0600 | Rating Details | |
| 2022-12-01 08:51:33 -0600 | Rating Details | |
| 2022-12-04 16:52:01 -0600 | Rating Details | |
| 2022-12-01 12:02:00 -0600 | Rating Details | |
| 2022-12-01 10:54:29 -0600 | Rating Details | |
| 2022-12-02 06:41:07 -0600 | Rating Details | |
| 2022-12-01 09:49:08 -0600 | Rating Details | |
| 2022-12-01 10:30:04 -0600 | Rating Details | |
| 2022-12-01 20:28:51 -0600 | Rating Details | |
| 2022-12-02 08:04:40 -0600 | Rating Details | |
| 2022-12-01 11:10:44 -0600 | Rating Details | |
| 2022-12-05 02:34:28 -0600 | Rating Details | |
| 2022-12-01 12:41:36 -0600 | Rating Details | |
| 2022-12-01 10:20:13 -0600 | Rating Details |